Four-year follow-up of patients with imatinib-resistant or intolerant chronic myeloid leukemia receiving dasatinib: efficacy and safety
{{custom_author.name}}, {{article.zuoZheEn}}
Four-year follow-up of patients with imatinib-resistant or intolerant chronic myeloid leukemia receiving dasatinib: efficacy and safety
[{{custom_ref.label}}] |
{{custom_citation.content}}
CrossRef
Pubmed
arXiv
Google scholar
|
/
〈 | 〉 |